===
EQS-News: M1 Kliniken AG / Key word(s): Forecast
M1 Kliniken AG: Management Board confirms growth targets
2024-06-21 / 12:47 CET/CEST
The issuer is solely responsible for the content of this announcement.
M1 Kliniken AG: Management Board confirms growth targets
Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake
in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of
over 2.3% in M1 Kliniken AG.
Attila Strauss emphasises: "I understand that such sales can lead to uncertainty and want to assure you that my
commitment and belief in the company and the investment is unwavering and long term. I firmly believe that M1 Med
Beauty has excellent growth opportunities in the global beauty market. Our latest business figures and forecasts remain
strong, with planned sales growth of up to 30% and an increase in EBIT of up to 40% in 2024. Our strategy and strong
market position give me great confidence in the future. Together with our dedicated team, we will continue to work on
developing M1 Med Beauty into the world's leading private provider of beauty treatments."
The Group's medium-term forecast envisages that M1 will operate a total of 150 to 200 specialist medical centres for
aesthetic medicine by the end of 2029. The Beauty segment should thus generate revenue of between EUR 200 and 300
million with an EBIT margin of at least 20 %. To put this into perspective: in 2023, the Beauty segment generated
revenue of around EUR 70.8 million with 58 locations.
About M1 Kliniken AG
M1 Kliniken AG is the leading fully integrated provider of aesthetic medical healthcare services in Europe. The Group
offers products and services of the highest quality standards in the aesthetic and surgical fields. Beauty medical
treatments are currently offered at 62 specialist centres under the "M1 Med Beauty" brand. With six operating rooms and
35 beds, the "M1 Schlossklinik" for Plastic and Aesthetic Surgery in Berlin is one of the largest and most modern
facilities of its kind in Europe. M1 Kliniken has been driving forward its internationalisation since the end of 2018
and is currently represented in ten countries.

Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M: ir@m1-kliniken.de
2024-06-21 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      M1 Kliniken AG 

Grünauer Straße 5
12557 Berlin
Germany

Phone:        +49 (0)30 347 47 44 14 
Fax:          +49 (0)30 347 47 44 17 
E-mail:       ir@m1-kliniken.de 
Internet:     https://www.m1-kliniken.de 
ISIN:         DE000A0STSQ8 
WKN:          A0STSQ 
Listed:       Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Hanover, Munich, 

Stuttgart, Tradegate Exchange
EQS News ID: 1930795

End of News EQS News Service
===
1930795 2024-06-21 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1930795&application_name=news

END) Dow Jones Newswires

June 21, 2024 06:47 ET (10:47 GMT)